Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel anticoagulant agents: introduction.

S Schulman1

  • 1Department of Medicine, Coagulation Unit, Division of Hematology, Karolinska Hospital, Stockholm, Sweden. sam.schulman@ks.se

Journal of Internal Medicine
|September 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Splanchnic vein thrombosis with and without myeloproliferative neoplasms: a comparative cohort study.

Journal of thrombosis and haemostasis : JTH·2026
Same author

Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients.

Medicina intensiva·2021
Same author

Anticoagulation strategies and risk of bleeding events in critically ill COVID-19 patients.

Medicina intensiva·2021
Same author

Associations of thrombocytopenia, transaminase elevations, and transfusion with laboratory coagulation tests in women with preeclampsia: a cross-sectional study.

International journal of obstetric anesthesia·2021
Same author

Lemierre syndrome - treat with antibiotics, anticoagulants or both?

Journal of internal medicine·2020
Same author

Assessment of clinically relevant bleeding as a surrogate outcome for major bleeding: validation by meta-analysis of randomized controlled trials.

Journal of thrombosis and haemostasis : JTH·2017

This review covers anticoagulant therapy principles and novel selective coagulation inhibitors in clinical trials. It explores mechanisms of action, and effects on inflammation and cancer.

Area of Science:

  • Pharmacology
  • Hematology
  • Oncology

Background:

  • Anticoagulant therapy is crucial for managing thrombotic disorders.
  • Novel anticoagulants offer targeted mechanisms with potentially improved safety profiles.
  • Emerging research suggests links between coagulation, inflammation, and cancer.

Purpose of the Study:

  • To discuss fundamental principles of anticoagulant therapy.
  • To introduce novel, selective coagulation inhibitors in advanced clinical trials.
  • To provide a broad overview of their mechanisms of action, including effects on inflammation and cancer.

Main Methods:

  • Review of current literature on anticoagulant therapy.
  • Discussion of principles guiding anticoagulant drug development.

Related Experiment Videos

  • Analysis of data from advanced clinical trials of novel inhibitors.

    • Main Results:

    • Identification of key principles for effective anticoagulant therapy.
    • Presentation of several selective coagulation inhibitors nearing clinical application.
    • Exploration of the multifaceted roles of coagulation factors beyond hemostasis.

    Conclusions:

    • Novel anticoagulants represent a significant advancement in thrombotic disorder management.
    • Understanding coagulation mechanisms is vital for developing targeted therapies.
    • Coagulation pathways are increasingly recognized for their roles in inflammation and cancer progression.